There’s about 270 different viruses that can infect humans, and in the fall and winter we're inside more where they can ...

This summary covers recent health events including investment in German firm Gerresheimer, updates on the U.S. Medicare drug ...

Meanwhile, demand for vaccines targeting respiratory syncytial virus are down in the U.S. Also, if you are uncertain about whether you might have covid or the flu, the newly approved at-home Healgen ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

Test results are pending on a worker who had contact with infected herds, California officials report. Meanwhile, federal scientists are studying H5N1 genes in dairy workers in search of mutations ...

Federal scientists are closely studying H5N1 genetic sequences from California dairy workers in search of any dangerous ...

Current health highlights include Sanofi, GSK, and CSL expanding bird flu vaccine efforts in the U.S. following a multi-state ...

The Biomedical Advanced Research and Development Authority (BARDA) has awarded $72 million to three vaccine companies to boost H5N1 vaccine production. CSL Seqirus, producing a cell-based vaccine, ...

The U.S. government has granted $72 million to European pharma giants GSK Plc (NYSE:GSK), Sanofi SA (NASDAQ:SNY) and ...

GSK , Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, a ...

The 2018-2019 influenza season is one such case. The vaccine’s effectiveness during that year was an abysmal 29%, according ...

Federal officials plan to double the stockpile of emergency bird flu vaccines as they identify more people infected with the ...